The significance of Ureaplasma urealyticum as a pathogenic agent in the paediatric population

Current Opinion in Infectious Diseases

Volumn 19, Issue 3, 2006, Pages 283-289

  Pinna, Georgia S ^a   Skevaki, Chrysanthi L ^b   Kafetzis, Dimitris A ^b,c  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

Author keywords

Arthritis; Children; Chloramphenicol; Chronic lung disease; Erythromycin; Macrolides; Neonates; Prematurity; Tetracyclines; Ureaplasma urealyticum

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; AZITHROMYCIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

AGE; ANTIBODY DETECTION; ARTHRITIS; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BONE MARROW TOXICITY; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD DISEASE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; DIGESTIVE SYSTEM INJURY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENTEROPATHY; HUMAN; HYPERTROPHIC PYLORUS STENOSIS; LIVER TOXICITY; NEWBORN DEATH; NEWBORN INFECTION; NONHUMAN; OSTEOMYELITIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PSEUDOMEMBRANOUS COLITIS; REVIEW; SEPSIS; SYMPTOM; UREAPLASMA UREALYTICUM; WHEEZING;

FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

EID: 33646697498     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qco.0000224824.73223.e7     Document Type: Review

References (89)

1. Blanchard A, Hentschel J, Duffy L, et al. Detection of Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid and in the respiratory tract of newborns. Clin Infect Dis 1993; 17 (Suppl. 1):S148-S153.
2. Cassel GH, Waites KB, Crouse DT. Mycoplasmal infections. In: Remongton JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant, 5th ed. Philadelphia, PA: The W.B. Saunders Co., Inc; 2001. pp. 733-767.
3. Skevaki C, Kafetzis DA. Ureaplasma urealyticum airway colonization and pulmonary outcome in neonates. Expert Rev Anti-Infect Ther 2003; 1:183-191.
4. Quin PA, Li HCS, Th'ng C, et al. Serological response to Ureaplasma urealyticum in the neonate. Clin Infect Dis 1993; 17 (Suppl. 1):S136-S143.
5. Kafetzis DA, Skevaki C, Skouteri V, et al. Maternal genital colonization with Ureaplasma urealyticum promotes preterm delivery. Association of the respiratory colonization of the premature infants with chronic lung disease and increased mortality. Clin Infect Dis 2004; 39:1113-1122.
6. Sanchez PJ, Regan JA. Vertical transmission of Ureaplasma urealyticum from mothers to preterm infants. Pediatr Infect Dis J 1990; 9:398-401.
7. Eschenbach DA. Ureaplasma urealyticum and premature birth. Clin Infect Dis 1993; 17 (Suppl. 1):S100-S106.
8. Cassel GH, Waites KB, Crouse DT, et al. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very low birth weight infants. Lancet 1988; 2:240-245.
9. Waites KB, Crouse DT, Philips JB III, et al. Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn. Pediatrics 1989; 83:79-85.
10. Quinn PA, Gillan E, Markestad T, et al. Intrauterine infection with Ureaplasma urealyticum as a cause of fatal neonatal pneumonia. Pediatr Infect Dis 1985; 4:538-543.
11. Brus F, van Waarde WM, Schoots C, et al. Fatal ureaplasmal pneumonia and sepsis in a newborn infant. Eur J Pediatr 1991; 150:782-783.
12. Tafari N, Ross S, Naeye RL, et al. Mycoplasmal T-strains and perinatal death. Lancet 1976; 1:108-109.
13. Waites KB, Rudd PT, Crouse DT, et al. Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet 1988; 1:17-21.
14. Panero A, Pacifico L, Rossi N, et al. Ureaplasma urealyticum as a cause of pneumonia in preterm infants: analysis of the white cells response. Arch Dis Child 1995; 73:37-40.
15. Gannon H. Ureaplasma urealyticum and its role in neonatal lung disease. Neonatal Netw 1993; 12:13-18.
16. Crouse DT, Odrezin GT, Cutter GR, et al. Radiographic changes associated with tracheal isolation of Ureaplasma urealyticum from neonates. Clin Infect Dis 1993; 17 (Suppl. 1):122-130.
17. Pacifico L, Panero A, Roggini M, et al. Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population. Pediatr Infect Dis J 1997; 16:579-586.
18. Dyke MP, Grauag A, Kohan R, et al. Ureaplasma urealyticum in a neonatal intensive care population. J Pediatr Child Health 1993; 29:295-297.
19. Walsh WF, Stanley S, Lally KP, et al. Ureaplasma urealyticum demonstrated by chronic lung biopsy in newborns with chronic lung disease. Pediatr Infect Dis J 1991; 10:823-827.
20. Payne NR, Steinberg SS, Ackerman P, et al. New prospective studies of the association of the Ureaplasma urealyticum colonization and chronic lung disease. Clin Infect Dis 1993; 17 (Suppl. 1):117-121.
21. Heggie AD, Bar-shain D, Boxerbaum B, et al. Identification and quantification of Ureaplasmas colonizing the respiratory tract and assessment of their role in the development of chronic lung disease in preterm infants. Pediatr Infect Dis J 2001; 20:854-859.
22. Sanchez PJ, Regan JA. Ureaplasma urealyticum colonization and chronic lung disease in low birth weight infants. Pediatr Infect Dis J 1988; 7:542-546.
23. Wang EEL, Frayha H, Watts J, et al. Role of Ureaplasma urealyticum and other pathogens in the development of chronic lung disease of prematurity. Pediatr Infect Dis J 1988; 7:547-551.
24. Payne NR, Steinberg SS, Stefan H, et al. The association of Ureaplasma urealyticum (Ureaplasma urea) colonization and bronchopulmonary disease in extremely premature newborn infants. Pediatr Res 1991; 29:285A.
25. Wang EE, Cassel GH, Sanchez PJ, et al. Ureaplasma urealyticum and chronic lung disease of prematurity: critical appraisal of the literature on causation. Clin Infect Dis 1993; 17:5112-5116.
26. Iles R, Lyon A, Ross P, et al. Infection with Ureaplasma urealyticum and mycoplasma hominis and the development with chronic lung disease in preterm infants. Acta Pediatr 1996; 85:482-484.
27. Garland SM, Bowman ED. Role of Ureaplasma urealyticum and Chlamydia trachomatis in lung disease in low birth weight infants. Pathology 1996; 28:266-269.
28. Hannaford K, Todd D, Jeffery H, et al. Role of Ureaplasma urealyticum in lung disease of prematurity. Arch Dis Child 1997; 81:162-167.
29. Perzigian RW, Adams JT, Weiner GM, et al. Ureaplasma urealyticum and chronic lung disease in very low birth weight infants during the exogenous surfactant era. Pediatr Infect Dis J 1998; 17:620-625.
30. Galetto Lacour A, Zamora S, Bertrand R, et al. Colonization by Ureaplasma urealyticum and chronic lung disease in premature newborn infants under 32 weeks of gestation. Arch Pediatr 2001; 8:39-46.
31. Ruf B, Klawer D, Reiss I, et al. Colonization of the airways with Ureaplasma urealyticum a risk factor for bronchopulmonary dysplasia in very low birth weight infants. Z Geburtshilfe Neonatol 2002; 206:187-192.
32. Smyth AR, Shaw NJ, Pratt BC, et al. Ureaplasma urealyticum and chronic lung disease. Eur J Pediatr 1993; 152:931-932.
33. Johnson B, Karrel AC, Ringertz S, et al. Neonatal Ureaplasma urealyticum colonization and chronic lung disease. Acta Pediatr 1994; 83:927-930.
34. van Waarde WM, Brus F, Okken A, et al. Ureaplasma urealyticum colonization, prematurity and bronchopulmonary dysplasia. Eur Resp J 1997; 10:886-890.
35. Agarwal P, Rajadurai VS, Pradeepkumar VK, Tan KW. Ureaplasma urealyticum and its association with chronic lung disease in Asian neonates. J Pediatr Child Health 2000; 36:487-490.
36. Schelonka RL, Katz B, Waites KB, Benjamin DK Jr. Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. Pediatr Infect Dis J 2005; 24:1033-1039. This metaanalysis reports an association between ureaplasma colonization and bronchopulmonary dysplasia, with the greatest reported effect seen in small studies.
37. Castro-Alcaraz S, Greenberg EM, Bateman DA, Regan JA. Patterns of colonization with Ureaplasma urealyticum during neonatal intensive care unit hospitalizations of very low birth weight infants and the development of chronic lung disease. Pediatrics 2002; 110:e45.
38. Gronick P, Schmale J, Soditt V, et al. Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease. Pediatr Pulm 2001; 31:331-338.
39. Groneck P, Goetze-Speer B, Speer CP. Inflammatory bronchopulmonary response of preterm infants with microbial colonization of the airways at birth. Arch Dis Child 1996; 14:51-53.
40. Patterson AM, Taciak V, Lovchik J, et al. Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants. Pediatr Infect Dis J 1998; 17:321-328.
41. Likitnukul S, Kusmiesz H, Nelson JD, McCracken GH Jr. Role of genital mycoplasmas in young infants with suspected sepsis. J Pediatr 1986; 109:971-974.
42. Stahelin-Massik J, Levy F, Friderich P, Schaad UB. Meningitis caused by Ureaplasma urealyticum in a full term neonate. Pediatr Infect Dis J 1994; 13:419-421.
43. Ollikainen J, Hiekkaniemi H, Korppi M, et al. Ureaplasma urealyticum cultured from brain tissue of preterm twins who died of intraventricular hemorrhage. Scand J Infect Dis 1993; 25:529-531.
44. Neal TJ, Roe MF, Shaw NJ. Spontaneously resolving Ureaplasma urealyticum meningitis. Eur J Pediatr 1994; 153:342-343.
45. Hentschel J, Abele-Horn M, Peters J. Ureaplasma urealyticum in the cerebrospinal fluid of a premature infant. Acta Paediatr 1993; 82:690-693.
46. Waites KB, Duffy LB, Crouse DT, et al. Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population. Pediatr Infect Dis J 1990; 9:241-245.
47. Mohiuddin AA, Corren J, Harbeck RJ, et al. Ureaplasma urealyticum chronic osteomyelitis in a patient with hypogammaglobulinemia. J Allergy Clin Immunol 1991; 87:104-107.
48. Jorup-Ronstrom C, Ahl T, Hammarstrom L, et al. Septic osteomyelitis and polyarthritis with Ureaplasma in hypogammaglobulinemia. Infection 1989; 17:301-303.
49. Izraeli S, Samra Z, Sirota L, et al. Genital mycopolasmas in preterm infants: prevalence and clinical significance. Eur J Pediatr 1991; 150:804-807.
50. Buckingham SC, Crouse DT, Knapp KM, Patrick CC. Pneumonitis associated with Ureaplasma urealyticum in children with cancer. Clin Infect Dis 2003; 36:225-228. E-pub 31 December 2002.
51. Ferrer A, Calico I, Manresa JM, et al. Microorganisms isolated in cases of pertussis-like syndrome. Enferm Infecc Microbiol Clin 2000; 18:433-438.
52. Stephenson J. Studies suggest a darker side of "benign microbes". JAMA 1997; 278:2051-2052.
53. Kundsin RB, DeLollis RD, Poulin SA. Ureaplasma urealyticum in young children with acute respiratory symptoms. Infect Dis Clin Pract 1996; 5:551-554.
54. Benn CS, Thorsen P, Jensen JS, et al. Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of anti-asthma medication in early childhood. J Allergy Clin Immunol 2002; 110:72-77.
55. Ingram DL, White ST, Lyna P, et al. Ureaplasma urealyticum and large colony mycoplasma colonization in female children and its relationship to sexual contact, age and race. Child Abuse Neglect 1992; 16:265-272.
56. Hammerschlag MR, Doraiswamy B, Cox P, et al. Colonization of sexually abused children with genital mycoplasmas. Sex Transm Dis 1987; 14:23-25.
57. Waites KB, Brown MB, Stagno S, et al. Associaton of genital mycoplasmas with exudative vaginitis in a 10-year old: a case of misdiagnosis. Pediatrics 1983; 71:250-252.
58. Poggio TV, Orlando N, Galanternik L, Grinstein S. Microbiology of acute arthropathies among children in Argentina: Mycoplasma pneumoniae and hominis and Ureaplasma urealyticum. Pediatr Infect Dis J 1998; 17:304-308.
59. Stuckey M, Quinn PA, Gelfand EW. Identification of Ureaplasma urealyticum (T-strain mycoplasma) in patient with polyarthritis. Lancet 1978; 28:917-920.
60. Geloni V, Fantini F. Reactive arthritis. Pediatr Med Chir 1990; 12:447-451.
61. Smith RJ. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum in a patient with Reiters disease. J Adolesc Health Care 1989; 10:155-159.
62. Bialasiewic AA, Holbach L. Ocular findings in infection-linked immune phenomena and secondary diseases (the so-called Reiter's syndrome). Klin Monatsbl Augenheilkd 1990; 196:196-201.
63. Haussain A, Lane W, Robson M, et al. Mycoplasma penetrans and other mycoplasmas in urine of HIV+ children. J Clin Microbiol 1999; 37:1518-1523.
64. Waites KB, Crouse DT, Cassel GH. Therapeutic considerations for Ureaplasma urealyticum infections in neonates. Clin Infect Dis 1993; 17 (Suppl. 1):S208-S214.
65. Waites K, Sims B, Crouse D, et al. Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection. Pediatr Infect Dis J 1994; 13:287-293.
66. Waites K, Crouse D, Cassel G. Therapeutic considerations for Ureaplasma urealyticum infection of neonates. Clin Infect Dis 1993; 17 (Suppl. 1):S208-S214.
67. Jonsson B, Rylander M, Faxelius G. Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. Acta Paediatr 1998; 87:1079-1084.
68. Heggie AD, Jacobs MR, Butler V, et al. Frequency and significance of isolation of Ureaplasma urealyticum and Mycoplasma hominis from cerebrospinal fluid and tracheal specimens from low birth weight infants. J Pediatr 1994; 124:956-961.
69. Lyon AJ, McColm J, Middlemist L, et al. Randomized trial of erythromycin in the development of chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998; 78:F10-F14.
70. Baier RJ, Loggins J, Krugger TE. Failure of erythromycin to eliminate airway colonization with Ureaplasma urealyticum in very low birth weight infants. BMC Pediatr 2003; 3:10.
71. Mabanta CG, Pryhuber GS, Weinberg GA, et al. Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst Rev 2003; 4:CD003744.
72. Mhanna MJ, Delong LJ, Aziz HF. The value of Ureaplasma urealyticum tracheal culture and treatment in premature infants following an acute respiratory deterioration. J Perinatol 2003; 23:541-544.
73. Bowman ED, Dharmaligan A, Fan WQ, et al. Impact of erythromycin or respiratory colonization of Ureplasma urealyticum and the development of chronic lung disease in extremely low birth weight infants. Pediatr Infect Dis J 1998; 17:615-620.
74. Baier J, Fajardo C. Early screening and treatment of Ureaplasma urealyticum in the very low birth weight infant does not prevent chronic lung disease. Pediatr Res 1992; 31:273A.
75. Goldenber R, Andrews W. Intrauterine infection and why preterm prevention programs have failed [Editorial]. Am J Publ Health 1996; 86:781-783.
76. Cassel G, Waites K, Watson H, et al. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 1993; 6:69-87.
77. Hauth J, Goldenberg R, Andrews W, et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333:1732-1736.
78. Egarter C, Leitich H, Karas H, et al. Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity. Am J Obstet Gynecol 1996; 174:589-597.
79. Kenyon SL, Taylor DJ, Tarnow-Mordi W. ORACLE Collaborative Group. Broad spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomized trial. ORACLE Collaborative Group. Lancet 2001; 357:979-988.
80. Kenyon SL, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group. Broad spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomized trial. ORACLE Collaborative Group. Lancet 2001; 357:989-994.
81. Klein LL, Gibbs RS. Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol 2004; 190:1493-1502.
82. Farrar HC, Walsh-Sukys MC, Kyllonen K, Blumer JL. Cardiac toxicity associated with intravenous erythromycin lactobionate: two case reports and a review of the literature. Pediatr Infect Dis J 1993; 12:688-691.
83. Matlow A, Th'ng C, Kovach D, et al. Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents. Antimicrob Agent Chemother 1998; 42:1290-1292.
84. Witt A, Sommer EM, Cichna M, et al. Placental passage of erythromycin surpasses other macrolide antibiotics. Am J Obstet Gynecol 2003; 188:816-819.
85. Shaw NJ, Pratt BC, Weindling AM. Ureaplasma and mycoplasma infections of the central nervous system in preterm infants [Letter]. Lancet 1989; 2:1530-1531.
86. Hentschel J, Abele-Horn M, Peters J. Ureaplasma urealyticum in the cerebrospinal fluid of a premature infant. Acta Paediatr 1993; 82:690-693.
87. Garland SM, Murton LJ. Neonatal meningitis caused by Ureaplasma urealyticum. Pediatr Infect Dis J 1987; 6:868-870.
88. Waites KB, Rudd PT, Grouse DT, et al. Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet 1988; 1:17-21.
89. Aujard Y, Maury L, Doit C, et al. Ureaplasma urealyticum and Mycoplasma hominis infections in newborns. Personal data and review of the literature. Arch Pediatr 2005; 12 (Suppl. 1):S12-S18.